SavedAdd your journal

Journals / Endoüroloji Bülteni / 2026 / Cilt: 18 Sayı: 3

The Efficacy of Simultaneous Ureterorenoscopy for Ipsilateral Ureter and Kidney Stone: A Single-Center Experience

İpsilateral Üreter ve Böbrek Taşlarında Eş Zamanlı Üreterorenoskopinin Etkinliği: Tek Merkez Deneyimi

Ilkın Hamıdzada(Istanbul Medeniyet University , Department of Urology)0009-0000-0550-250X
Özgür Arıkan(ISTANBUL MEDENIYET UNIVERSITY)0000-0002-4647-4864
Muhammet Talha Nuroğlu(ISTANBUL MEDENIYET UNIVERSITY)0009-0000-8226-0436
Elbrus Fehruzlu(ISTANBUL MEDENIYET UNIVERSITY)0009-0006-7434-1774
Ferhat Keser(ISTANBUL MEDENIYET UNIVERSITY)0000-0002-2803-6481
Asıf Yıldırım(ISTANBUL MEDENIYET UNIVERSITY)0000-0002-3386-971X
Pages
117–125
Publication Date
2026-09-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The overall 1-month SFR was 75.9%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to evaluate the efficacy and safety of simultaneous endourological management of ureteral and ipsilateral renal stones and to identify predictive factors associated with stone-free outcomes.
📊
Key Findings & Data:Stone-free rates (SFR) were assessed on postoperative day 1 and at 1 month.
💡
Conclusion & Impact:Results: The overall 1-month SFR was 75.9%.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Litotripsi · eş zamanlı tedavi · üreter ve böbrek taşı

Abstract

Objective: This study aimed to evaluate the efficacy and safety of simultaneous endourological management of ureteral and ipsilateral renal stones and to identify predictive factors associated with stone-free outcomes. Materials and Methods: A retrospective analysis was conducted on seventy-nine patients who underwent single-session treatment for concurrent ureteral and ipsilateral renal stone. Demographic data, stone characteristics, operative details, and postoperative outcomes were collected. Stone-free rates (SFR) were assessed on postoperative day 1 and at 1 month. Comparative analyses were performed to determine factors associated with 1-month SFR. Results: The overall 1-month SFR was 75.9%. Renal stone size, ureteral stone density (HU), hydronephrosis grade, and number of stones were significant predictors of SFR (p < 0.05). Patients who were stone-free on postoperative 1 day were significantly more likely to remain stone-free at 1 month (p < 0.001). Larger renal stones and a higher number of stones were associated with decreased success rates. Complication rates were low, with 6.3% experiencing postoperative events, most of which were minor. Auxiliary procedures were required in 16.5% of patients during follow-up. Conclusion: Simultaneous management of ureteral and ipsilateral renal stones is a safe and effective treatment option, providing high SFR with low morbidity. Stone size and number of stones are the key determinants of postoperative success and should be considered during preoperative planning.

Özet

Amaç: Bu çalışma, üreteral ve ipsilateral renal taşların eşzamanlı endoürolojik tedavisinin etkinliğini ve güvenliğini değerlendirmeyi ve taşsızlık sonuçlarıyla ilişkili prediktif faktörleri belirlemeyi amaçlamıştır. Gereç ve Yöntemler: Üreteral ve ipsilateral renal taşın eşzamanlı olarak tek seansta tedavi edildiği yetmiş dokuz hastaya ait retrospektif bir analiz gerçekleştirildi. Demografik veriler, taş özellikleri, operatif detaylar ve postoperatif sonuçlar kaydedildi. Taşsızlık oranları (SFR), postoperatif 1. gün ve 1. ayda değerlendirildi. Bir aylık taşsızlık ile ilişkili faktörleri belirlemek amacıyla karşılaştırmalı analizler yapıldı. Bulgular: 1 aylık taşsızlık oranı %75,9 olarak saptandı. Renal taş boyutu, üreteral taş yoğunluğu (HU), hidronefroz derecesi ve taş sayısı SFR için anlamlı prediktörlerdi (p < 0.05). Postoperatif 1. günde taşsız olan hastaların 1. ayda da taşsız kalma olasılığı anlamlı olarak daha yüksekti (p < 0.001). Daha büyük renal taşlar ve daha yüksek taş sayısı başarı oranlarının azalmasıyla ilişkili bulundu. Komplikasyon oranları düşük olup, hastaların %6.3’ünde çoğunluğu minör olan postoperatif olaylar izlendi. Takip sürecinde hastaların %16.5’inde ek girişimlere ihtiyaç duyuldu. Sonuç: Üreteral ve ipsilateral renal taşların eşzamanlı yönetimi, yüksek taşsızlık oranı ve düşük morbidite ile güvenli ve etkili bir tedavi seçeneğidir. Taş boyutu ve taş sayısı, postoperatif başarının temel belirleyicileridir ve preoperatif planlama sürecinde dikkate alınmalıdır.

🔖

Cite This Article

Hamıdzada, I., Arıkan, Ö., Nuroğlu, M. T., Fehruzlu, E., Keser, F., Yıldırım, A. (2026). The Efficacy of Simultaneous Ureterorenoscopy for Ipsilateral Ureter and Kidney Stone: A Single-Center Experience. Endoüroloji Bülteni, Cilt: 18 Sayı: 3, 117–125. https://doi.org/10.54233/endourolbull-1840851

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Saeed S, Ullah A, Ahmad J, Hamid S. The prevalence of incidentally detected urolithiasis in subjects undergoing computerized tomography. Cureus. 2020;12(9):e10374. https://doi.org/10.7759/cureus.10374
  2. Marchini GS, Vicentini FC, Monga M, Torricelli FC, Danilovic A, Brito AH, et al. Irreversible renal function impairment due to silent ureteral stones. Urology. 2016; 93:33–9. https://doi.org/10.1016/j.urology.2016.02.042
  3. Selmi V, Sarı S, Çakıcı MÇ, Özdemir H, Kartal İG, Özok HU, et al. Does previous failed shockwave lithotripsy treatment have an influence on retrograde intrarenal surgery outcome? J Laparoendosc Adv Surg Tech A. 2019;29(5):627–30. https://doi.org/10.1089/lap.2018.0487
  4. Skolarikos, A., Geraghty, R., Somani, B., Tailly, T., Jung, H., Neisius, A., Petřík, A., Kamphuis, G. M., Davis, N., Bezuidenhout, C., Lardas, M., Gambaro, G., Sayer, J. A., Lombardo, R., & Tzelves, L. (2025). European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis. European urology, 88(1), 64–75. https://doi.org/10.1016/j.eururo.2025.03.011
  5. Ozden E, Mercimek MN, Bostanci Y, Yakupoglu YK, Sirtbas A, Sarikaya S. Long-term outcomes of percutaneous nephrolithotomy in patients with chronic kidney disease: a single-center experience. Urology. 2012;79(5):990–4. https://doi.org/10.1016/j.urology.2011.10.066
  6. Pan D, Zhang L, Pan J, Yang B, Gao P, Zhang K. A retrospective analysis on the effect of single-channel minimally invasive percutaneous nephrolithotomy combined with retrograde flexible ureteroscopy using the completely lateral decubitus and semi-lithotomy positions to treat complex kidney stones. Transl Androl Urol. 2021;10(9):3638–45. https://doi.org/10.21037/tau-21-635
  7. Hyams ES, Monga M, Pearle MS, Antonelli JA, Semins MJ, Assimos DG, et al. A prospective, multi-institutional study of flexible ureteroscopy for proximal ureteral stones smaller than 2 cm. J Urol. 2015;193(1):165–9. https://doi.org/10.1016/j.juro.2014.07.002
  8. Traxer O, Wendt-Nordahl G, Sodha H, Rassweiler J, Meretyk S, Tefekli A, et al. Differences in renal stone treatment and outcomes for patients treated either with or without the support of a ureteral access sheath: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study. World J Urol. 2015;33(12):2137–44. https://doi.org/10.1007/s00345-015-1582-8
  9. Kronenberg P, Somani B. Advances in lasers for the treatment of stones: a systematic review. Curr Urol Rep. 2018;19(6):45. https://doi.org/10.1007/s11934-018-0807-y
  10. Zeng G, Zhong W, Mazzon G, Choong S, Pearle M, Agrawal M, et al. International Alliance of Urolithiasis (IAU) guideline on percutaneous nephrolithotomy. Urology Herald. 2022;10(4):179–200. https://doi.org/10.21886/2308-6424-2022-10-4-179-200
  11. Taylor E, Miller J, Chi T, Stoller ML. Complications associated with percutaneous nephrolithotomy. Transl Androl Urol. 2012;1(4):223–8. https://doi.org/10.3978/j.issn.2223-4683.2012.12.01
  12. Zhu Z, Chi W, Zhang C, Jia W, Sun G. Utilization of flexible ureteroscopy in conjunction with flexible and navigable suction ureteral access sheaths for the management of 1–2 cm complex lower calyceal calculi. BMC Urol. 2025;25(1):290. https://doi.org/10.1186/s12894-025-01987-1
  13. Resorlu B, Unsal A, Gulec H, Oztuna D. A new scoring system for predicting stone-free rate after retrograde intrarenal surgery: the Resorlu–Unsal stone score. Urology. 2012;80(3):512–8. https://doi.org/10.1016/j.urology.2012.02.072
  14. Desai M, Grover R, Manohar T, Ganpule A. Simultaneous bilateral percutaneous nephrolithotomy: a single-center experience. J Endourol. 2007;21(5):508–14. https://doi.org/10.1089/end.2006.0401
  15. Zeng G, Zhu W, Li J, Zhao Z, Zeng T, Liu C, et al. The comparison of minimally invasive percutaneous nephrolithotomy and retrograde intrarenal surgery for stones larger than 2 cm in patients with a solitary kidney: a matched-pair analysis. World J Urol. 2015;33(8):1159–64. https://doi.org/10.1007/s00345-014-1420-4
  16. Marguet CG, Springhart WP, Tan YH, Patel A, Undre S, Albala DM, et al. Simultaneous combined use of flexible ureteroscopy and percutaneous nephrolithotomy to reduce the number of access tracts in the management of complex renal calculi. BJU Int. 2005;96(7):1097–100. https://doi.org/10.1111/j.1464-410X.2005.05808.x
  17. Ghani KR, Wolf JS Jr. What is the stone-free rate following flexible ureteroscopy for kidney stones? Nat Rev Urol. 2015;12(5):281–8. https://doi.org/10.1038/nrurol.2015.74